Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Shares Rise on News of Influenza Dx Service

NEW YORK, Dec. 6 (GenomeWeb News) - Shares in CombiMatrix were up $.07, or 4 percent, at $1.90 in mid-day trading after the company said it plans to offer a DNA-based microarray service to identify types of influenza.


The array will enable researchers to genetically identify influenza types, including the H5N1 bird flu. The company said the test can be run on both animal and human samples.


CombiMatrix Molecular Diagnostics, a wholly owned subsidiary of CombiMatrix formed in May, will offer the analysis for research purposes because the array is not an FDA approved product.


The Influenza microarray, part of CombiMatrix's CatalogArray product line, can detect and accurately type flu strains such as the H5N1 bird flu, as well as provide information on mutations and novel strains of flu not yet seen, the company said.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.